- Home
- ALRM vs KNSA Comparison
ALRM vs KNSA Comparison
Compare ALRM & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALRM
- KNSA
- Stock Information
- Founded
- ALRM 2000
- KNSA 2015
- Country
- ALRM United States
- KNSA United Kingdom
- Employees
- ALRM N/A
- KNSA N/A
- Industry
- ALRM Computer Software: Prepackaged Software
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- ALRM Technology
- KNSA Health Care
- Exchange
- ALRM Nasdaq
- KNSA Nasdaq
- Market Cap
- ALRM 2.8B
- KNSA 2.6B
- IPO Year
- ALRM 2015
- KNSA 2018
- Fundamental
- Price
- ALRM $55.22
- KNSA $35.43
- Analyst Decision
- ALRM Buy
- KNSA Strong Buy
- Analyst Count
- ALRM 6
- KNSA 6
- Target Price
- ALRM $64.33
- KNSA $40.83
- AVG Volume (30 Days)
- ALRM 319.0K
- KNSA 402.6K
- Earning Date
- ALRM 11-06-2025
- KNSA 10-28-2025
- Dividend Yield
- ALRM N/A
- KNSA N/A
- EPS Growth
- ALRM 17.96
- KNSA N/A
- EPS
- ALRM 2.37
- KNSA 0.07
- Revenue
- ALRM $975,867,000.00
- KNSA $529,332,000.00
- Revenue This Year
- ALRM $7.68
- KNSA $37.21
- Revenue Next Year
- ALRM $4.35
- KNSA $11.99
- P/E Ratio
- ALRM $23.26
- KNSA $538.95
- Revenue Growth
- ALRM 7.81
- KNSA 56.18
- 52 Week Low
- ALRM $48.23
- KNSA $17.82
- 52 Week High
- ALRM $70.06
- KNSA $37.34
- Technical
- Relative Strength Index (RSI)
- ALRM 42.80
- KNSA 57.08
- Support Level
- ALRM $55.00
- KNSA $35.72
- Resistance Level
- ALRM $56.85
- KNSA $37.34
- Average True Range (ATR)
- ALRM 1.12
- KNSA 1.01
- MACD
- ALRM -0.28
- KNSA -0.12
- Stochastic Oscillator
- ALRM 5.02
- KNSA 53.31
About ALRM Alarm.com Holdings Inc.
Alarm.com Holdings Inc has a cloud-based platform that offers an expansive suite of IoT solutions addressing world-wide opportunities in the residential, multi-family, small business and enterprise commercial markets. It has two reportable segments: Alarm.com & Other. The Alarm.com segment represents the cloud-based Software platforms for intelligently connected property & related solutions. The other segment is focused on researching, developing & offering residential & commercial automation solutions & energy management products & services in adjacent markets. The majority of revenue is from the Alarm.com segment. The platform allows home & business owners to secure their properties and automate & control an array of connected devices.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.